Get the Stockscreener App
0.281
0.57%
-0.0016
After Hours:
.28
-0.001
-0.36%
Vistagen Therapeutics Inc Stock (VTGN) Forecast
The Vistagen Therapeutics Inc (VTGN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $21.13, representing a +7,419% increase from the current price of $0.281. The highest analyst price target is $21.54, and the lowest is $20.72.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VTGN Price Target
Average 22.64
(+7,958% Upside)
Is Vistagen Therapeutics Inc (VTGN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 52.63 | Neutral |
| STOCH(9,6) | 19.80 | Buy |
| STOCHRSI(14) | 37.30 | Neutral |
| MACD(12,26) | 0.0107 | Buy |
| ADX(14) | 29.44 | Buy |
| William %R | -82.40 | Buy |
| CCI(14) | 37.72 | Neutral |
Buy: 4
Sell: 0
Neutral: 3
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.2846
Sell
|
0.284
Sell
|
| MA20 |
0.2617
Buy
|
0.2723
Buy
|
| MA50 |
0.2571
Buy
|
0.2878
Sell
|
| MA100 |
0.3792
Sell
|
0.4109
Sell
|
| MA200 |
0.535
Sell
|
0.9029
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, VTGN could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on VTGN, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 52.63 indicates that VTGN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 19.8 indicates that VTGN is oversold. This indicates that VTGN price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 37.3 indicates that VTGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.44 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 37.72 indicates that VTGN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term VTGN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Vistagen Therapeutics Inc financial reports and earnings history, Vistagen Therapeutics Inc (VTGN) stock could reach $10.26 by 2030, $87.03 by 2040 and $110.90 by 2050. See the projected annual prices until 2050 of the Vistagen Therapeutics Inc stock below:
- Vistagen Therapeutics Inc (VTGN) is expected to reach an average price of $68.77 in 2035, with a high prediction of $68.90 and a low estimate of $67.18. This indicates an $24,375% rise from the last recorded price of $0.281.
- Vistagen Therapeutics Inc (VTGN) stock is projected to chart a bullish course in 2040, with an average price target of $87.02, representing an $30,869% surge from its current level. The forecast ranges from a conservative $86.04 to a sky-high $87.03.
- Our analysts predict Vistagen Therapeutics Inc (VTGN) to jump 36,159% by 2045, soaring from $100.64 to an average price of $101.89, potentially reaching $101.91. While $100.64 is the low estimate, the potential upside is significant.
- Vistagen Therapeutics Inc (VTGN) stock is expected to climb by 2050, reaching an average of $110.79, a $39,327% jump from its current level. However, a wide range of estimates exists, with high and low targets of $110.90 and $109.34, respectively, highlighting the market's uncertainty.
Vistagen Therapeutics Inc Stock (VTGN) Year by Year Forecast
Vistagen Therapeutics Inc Stock (VTGN) Price Forecast for 2026
The predicted value for Vistagen Therapeutics Inc (VTGN) in 2026 is set at an average of $18.01. Estimates vary from a peak of $21.93 to a trough of $14.08, indicating an +6,308% surge from the present price of $0.281.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $21.43 | $20.72 | $21.54 | +7,525% |
| December, 2026 | $21.67 | $21.47 | $21.93 | +7,612% |
Vistagen Therapeutics Inc Stock (VTGN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Vistagen Therapeutics Inc (VTGN) is $23.42, with a high forecast of $25.22 and a low forecast of $21.61. This indicates an +8,233% increase from the last price of $0.281.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.67 | $21.61 | $21.91 | +7,611% |
| February, 2027 | $21.97 | $21.62 | $22.18 | +7,717% |
| March, 2027 | $22.20 | $21.76 | $22.21 | +7,800% |
| April, 2027 | $22.48 | $22.20 | $22.74 | +7,899% |
| May, 2027 | $22.66 | $22.33 | $22.85 | +7,966% |
| June, 2027 | $22.93 | $22.74 | $23.13 | +8,059% |
| July, 2027 | $23.37 | $22.97 | $23.39 | +8,215% |
| August, 2027 | $23.94 | $23.37 | $24.24 | +8,420% |
| September, 2027 | $24.15 | $23.86 | $24.23 | +8,493% |
| October, 2027 | $24.50 | $24.25 | $24.57 | +8,620% |
| November, 2027 | $24.87 | $24.54 | $24.95 | +8,751% |
| December, 2027 | $24.63 | $24.30 | $25.22 | +8,666% |
Vistagen Therapeutics Inc Stock (VTGN) Price Forecast for 2028
In 2028, Vistagen Therapeutics Inc (VTGN) is projected to reach an average price of $28.85, with a high projection of $32.97 and a low estimate of $24.73. This indicates an +10,167% rise from the last price of $0.281.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $25.08 | $24.73 | $25.09 | +8,824% |
| February, 2028 | $25.48 | $25.17 | $25.50 | +8,968% |
| March, 2028 | $26.00 | $25.58 | $26.01 | +9,151% |
| April, 2028 | $26.41 | $26.09 | $26.44 | +9,299% |
| May, 2028 | $26.92 | $26.52 | $26.96 | +9,481% |
| June, 2028 | $27.42 | $27.02 | $27.45 | +9,659% |
| July, 2028 | $27.86 | $27.52 | $28.02 | +9,814% |
| August, 2028 | $28.35 | $27.96 | $28.39 | +9,988% |
| September, 2028 | $28.78 | $28.45 | $28.80 | +10,141% |
| October, 2028 | $29.19 | $28.87 | $29.21 | +10,288% |
| November, 2028 | $29.73 | $29.30 | $29.75 | +10,482% |
| December, 2028 | $31.90 | $29.80 | $32.97 | +11,252% |
Vistagen Therapeutics Inc Stock (VTGN) Price Forecast for 2029
The 2029 price forecast for Vistagen Therapeutics Inc Stock (VTGN) is $32.19 on average, with a high prediction of $55.49 and a low estimate of $8.8856. This represents an +11,354% increase from the previous price of $0.281.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $32.38 | $31.89 | $32.44 | +11,424% |
| February, 2029 | $36.41 | $32.30 | $55.49 | +12,859% |
| March, 2029 | $37.37 | $35.82 | $38.66 | +13,198% |
| April, 2029 | $35.28 | $34.76 | $37.46 | +12,457% |
| May, 2029 | $34.95 | $34.83 | $35.88 | +12,337% |
| June, 2029 | $36.46 | $35.04 | $36.60 | +12,873% |
| July, 2029 | $38.37 | $36.59 | $38.71 | +13,556% |
| August, 2029 | $38.55 | $38.06 | $39.31 | +13,618% |
| September, 2029 | $39.13 | $38.42 | $39.64 | +13,827% |
| October, 2029 | $38.90 | $38.53 | $39.72 | +13,743% |
| November, 2029 | $39.92 | $38.98 | $40.68 | +14,105% |
| December, 2029 | $8.9228 | $8.8856 | $40.41 | +3,075% |
Vistagen Therapeutics Inc Stock (VTGN) Price Forecast for 2030
Vistagen Therapeutics Inc Stock (VTGN) is expected to reach an average price of $14.51 in 2030, with a high forecast of $19.91 and a low forecast of $9.1158. This signifies an +5,065% surge from the last price of $0.281.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $10.19 | $9.1158 | $10.26 | +3,528% |
| February, 2030 | $10.96 | $10.40 | $11.00 | +3,800% |
| March, 2030 | $11.72 | $11.12 | $11.79 | +4,072% |
| April, 2030 | $12.69 | $11.84 | $12.87 | +4,415% |
| May, 2030 | $14.12 | $12.89 | $14.21 | +4,927% |
| June, 2030 | $15.06 | $14.23 | $15.39 | +5,259% |
| July, 2030 | $15.33 | $15.07 | $15.92 | +5,354% |
| August, 2030 | $16.64 | $15.53 | $16.90 | +5,822% |
| September, 2030 | $17.35 | $16.71 | $17.45 | +6,073% |
| October, 2030 | $18.43 | $17.54 | $18.56 | +6,458% |
| November, 2030 | $19.04 | $18.59 | $19.19 | +6,676% |
| December, 2030 | $19.84 | $19.13 | $19.91 | +6,962% |
0.05%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):